Click to search for your profile
Click to search for condition or expert
Click to open main menu
X-Linked Lymphoproliferative Disease Clinical Trials
Find X-Linked Lymphoproliferative Disease clinical trials near you.
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
44
Start Date:
May 1, 2021
Constitutive IL7 (C7R) Modified EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
10
Start Date:
March 2021
Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation
Search for trials
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
12
Start Date:
February 20, 2021
Pilot Trial of Leflunomide in Patients With CD30+ Lymphoproliferative Disorders
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug, Procedure, Radiation
Participants:
56
Start Date:
September 22, 2020
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immunodeficiency Diseases
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Diagnostic Test, Drug
Participants:
62
Start Date:
September 2, 2020
Phase II Study of Rituximab and Acalabrutinib in Newly Diagnosed B Cell Post Transplant Lymphoproliferative Disorder (PTLD)
Clinical Trial
Status:
Recruiting
Phase:
Early Phase 1
Intervention Type:
Drug
Participants:
50
Start Date:
August 2020
Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
10
Start Date:
July 7, 2020
Ex-vivo Delivery of Rituximab to Prevent Post-transplant Lymphoproliferative Disease in Epstein-Barr Virus Mismatch Lung Transplant Recipients: A Pilot Trial
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
108
Start Date:
May 12, 2020
A Phase I/II Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK 001) in Multiple Myeloma Patients Following Autologous Stem Cell Transplant in the Front-line Setting.
Clinical Trial
Status:
Recruiting
Intervention Type:
Diagnostic Test
Participants:
500
Start Date:
January 3, 2020
EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients - Early Identification of Increased Risk of Infection and Cancer for Individualised Immunosuppression.
Clinical Trial
Status:
Recruiting
Participants:
40
Start Date:
August 25, 2019
Lymphoproliferative Disorders After Diagnosis of Childhood Acute Lymphoblastic Leukemia/Lymphoma
Clinical Trial
Status:
Recruiting
Participants:
1650
Start Date:
July 3, 2019
Oxford Pre-cancerous Lymphoproliferative Disorders: Analysis and Interception Study
Clinical Trial
Status:
Recruiting
Phase:
Early Phase 1
Intervention Type:
Biological, Procedure
Participants:
18
Start Date:
May 31, 2019
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Showing 1-12 of 60
Next